share_log

Moderna | 144: Notice of proposed sale of securities pursuant to Rule 144

Moderna | 144: Notice of proposed sale of securities pursuant to Rule 144

Moderna | 144:擬議出售證券
美股SEC公告 ·  09/04 04:01
牛牛AI助理已提取核心訊息
Moderna, Inc. officer Shannon Thyme is set to sell 114 common shares of the company on 09/03/2024, with an aggregate market value of $8,776.75. The shares were acquired on 08/30/2024 as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a series of sales over the past three months, where a total of 6,781 shares were sold for gross proceeds of approximately $901,314.55.
Moderna, Inc. officer Shannon Thyme is set to sell 114 common shares of the company on 09/03/2024, with an aggregate market value of $8,776.75. The shares were acquired on 08/30/2024 as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a series of sales over the past three months, where a total of 6,781 shares were sold for gross proceeds of approximately $901,314.55.
Moderna, Inc.官員Shannon Thyme計劃於09/03/2024出售114股該公司普通股,市值爲$8,776.75。這些股票是在08/30/2024作爲限制性股票授予的一部分獲得的,並被視爲發行人給予的補償。這次交易是在過去三個月內一系列銷售的基礎上進行的,共計出售了6,781股,總收入約爲$901,314.55。
Moderna, Inc.官員Shannon Thyme計劃於09/03/2024出售114股該公司普通股,市值爲$8,776.75。這些股票是在08/30/2024作爲限制性股票授予的一部分獲得的,並被視爲發行人給予的補償。這次交易是在過去三個月內一系列銷售的基礎上進行的,共計出售了6,781股,總收入約爲$901,314.55。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。